Table 3.
Phenotype | Disorder | Genes Involved | Chromosome | References |
---|---|---|---|---|
High LDL-C | Familial hypercholesterolemia | LDLR | 19p13.3 | [14,15] |
Familial defective apolipoprotein B | APOB | 2p24-p23 | [14,15] | |
Autosomal dominant hypercholesterolemia type 3 (PCSK9 gain of function) |
PCSK9 | 1p32.3 | [14,15] | |
Autosomal dominant hypercholesterolemia type 4 | STAP1 | 4q13.2 | [14,15] | |
Autosomal dominant hypercholesterolemia type 5 | APOE | 19q13 | [14,15] | |
Autosomal recessive hypercholesterolemia | LDLRAP1 (ARH) | 1p36-p35 | [14,15] | |
Cholesterol ester storage disease | LIPA | 10q21.31 | [14,15] | |
Sitosterolemia | ABCG5/ABCG8 | 2p21 | [14,15] | |
Low LDL-C | Abetalipoproteinemia (Bassen–Kornzweig syndrome) |
MTTP | 4q24 | [13,14] |
Hypobetalipoproteinemia | APOB | 2p24-p23 | [13,14] | |
PCSK9 deficiency with low LDL-C levels (PCSK9 loss of function) |
PCSK9 | 1p32.3 | [13,14] | |
Familial combined hypolipidemia (ANGPTL3 deficiency) |
ANGPTL3 | 1p31.1-p22.3 | [13,14] | |
Chylomicron retention disease (Anderson disease) |
SAR1B | 5p31.1 | [13,14] |